C 431 (Darifenacin Hydrobromide Extended-Release 7.5 mg)
Pill with imprint C 431 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Cipla USA Inc..
Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 431
Darifenacin Hydrobromide Extended-Release
- Imprint:
- C 431
- Strength:
- 7.5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cipla USA Inc.
- National Drug Code (NDC):
- 69097-0431
More about darifenacin
- Darifenacin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 20 Reviews
- Drug class: urinary antispasmodics
Consumer resources
Other brands: Enablex
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
